GSK Completes Spin Off Of Its Consumer Healthcare Business - Yahoo Finance
WEBJul 18, 2022 · In this article: GSK plc (NYSE: GSK) has completed the demerger of the Consumer Healthcare business to form the Haleon Group. Reuters reported that shares in Haleon started trading at 330...
Completion of the demerger of Haleon and share consolidation of GSK
WEBJul 18, 2022 · GSK plc (LSE/NYSE: GSK) has today (Monday 18 July 2022) completed the demerger of the Consumer Healthcare business from the GSK Group to form the Haleon Group.
Completion of GSK Share Consolidation
WEBJul 18, 2022 · It is expected that “regular-way” trading with respect to existing GSK ADSs will end at market open on Tuesday 19 July 2022 and that “regular-way” trading with respect to new GSK ADSs will commence on the New York Stock Exchange (the “NYSE”) at market open on Friday 22 July 2022.
Consumer Healthcare Demerger - GSK
WEBOn Monday 18 July 2022, GSK plc (“GSK” or the “Company”) separated its Consumer Healthcare business from the GSK Group to form Haleon plc (“Haleon”), an independent listed company.
GlaxoSmithKline demerger: GSK spin-off Haleon date and details …
WEBAug 12, 2022 · Now the demerger has taken place, the total issued ordinary share capital of Haleon will mean that GSK shareholders will jointly own 54.5%, Pfizer will continue to hold 32%, GSK will hold 6% and 7.5% will be held by Scottish limited partnerships, which provide funding to GSK pensions.
GSK split will help deal with ‘perennial underperformance’, says …
WEBJul 16, 2022 · The split will strengthen GSK’s balance sheet, as Haleon will take on more of the debt and GSK will receive a £7bn dividend and retain a 6 per cent stake to sell down over time.
GSK spins off Haleon in biggest European listing for a decade
WEBJul 18, 2022 · Haleon becomes the world's biggest standalone consumer health business, home to brands including Sensodyne toothpaste and Advil painkillers.
GSK completes split; Haleon launches as consumer health …
WEBJul 18, 2022 · GSK, previously operated as GlaxoSmithKline, on Monday completed the spinoff of its consumer product unit into a separate $36 billion business operating as Haleon.
GSK consumer business split off after investor pressure from …
WEBJun 23, 2021 · LONDON — British pharmaceutical giant GlaxoSmithKline faces a crunch meeting with investors on Wednesday after announcing a new strategy for the next decade centered on the splitting off of the...
GSK Completes Demerger of Consumer Healthcare Business
WEBJul 19, 2022 · Per GSK, this separation will help the company to not only focus on its existing business segments, which comprise Pharmaceuticals (respiratory, HIV, immuno-inflammation and oncology) and...
Skip to content